4DMedical Limited (4DX.AX) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-06-30. 4DX.AX files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.33% | 30.00% | Pass |
| Interest-bearing investments | 0.27% | 30.00% | Pass |
| Non-permissible income | 5.80% | 5.00% | Fail |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.09% | 33.00% | Pass |
| Interest-bearing investments | 7.26% | 33.00% | Pass |
| Non-liquid assets | 91.49% | at least 20.00% | Pass |
| Non-permissible income | 5.80% | 5.00% | Fail |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.09% | 33.33% | Pass |
| Cash + interest-bearing securities | 7.26% | 33.33% | Pass |
| Accounts receivable | 8.51% | 33.33% | Pass |
| Non-permissible income | 5.80% | 5.00% | Fail |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.09% | 33.33% | Pass |
| Cash + interest-bearing securities | 7.26% | 33.33% | Pass |
| Accounts receivable | 8.51% | 50.00% | Pass |
| Non-permissible income | 5.80% | 5.00% | Fail |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.57% | 33.00% | Pass |
| Cash + interest-bearing securities | 0.46% | 33.00% | Pass |
| Accounts receivable | 0.08% | 33.00% | Pass |
| Non-permissible income | 5.80% | 5.00% | Fail |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.77% | 33.00% | Pass |
| Cash + interest-bearing securities | 0.61% | 49.00% | Pass |
| Accounts receivable | 0.11% | 49.00% | Pass |
| Non-permissible income | 5.80% | 5.00% | Fail |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.77% | 33.33% | Pass |
| Cash + interest-bearing securities | 0.61% | 33.33% | Pass |
| Accounts receivable | 0.72% | 49.00% | Pass |
| Non-permissible income | 5.80% | 5.00% | Fail |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 41.70 | NEUTRAL |
| Stochastic %K (14) | 8.06 | BUY |
| CCI (20) | -105.22 | BUY |
| Williams %R (14) | -91.94 | BUY |
| MACD (12,26,9) | -0.02 | SELL |
| ROC (10) | -7.69 | SELL |
| Momentum (10) | -0.28 | SELL |
| EMA (10) | 3.48 | SELL |
| SMA (10) | 3.44 | SELL |
| EMA (20) | 3.58 | SELL |
| SMA (20) | 3.61 | SELL |
| EMA (30) | 3.65 | SELL |
| SMA (30) | 3.81 | SELL |
| EMA (50) | 3.74 | SELL |
| SMA (50) | 3.74 | SELL |
| EMA (100) | 3.83 | SELL |
| SMA (100) | 3.85 | SELL |
| EMA (200) | 3.56 | SELL |
| SMA (200) | 3.97 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Medical Devices
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.
